Skip to main content

and
  1. Article

    Open Access

    ProfhEX: AI-based platform for small molecules liability profiling

    Off-target drug interactions are a major reason for candidate failure in the drug discovery process. Anticipating potential drug’s adverse effects in the early stages is necessary to minimize health risks to p...

    Filippo Lunghini, Anna Fava, Vincenzo Pisapia in Journal of Cheminformatics (2023)

  2. Article

    Open Access

    Relevance of Spike/Estrogen Receptor-α interaction for endothelial-based coagulopathy induced by SARS-CoV-2

    Silvia Stella Barbieri, Franca Cattani in Signal Transduction and Targeted Therapy (2023)

  3. No Access

    Chapter

    A European Drug-Discovery Platform: From In Silico to Experimental Validation

    The COVID-19 pandemic highlighted an urgent need for streamlined drug development processes. Enhanced virtual screening methods could expedite drug discovery via rapid screening of large virtual compound libra...

    Gianluca Palermo, Daniela Iaconis, Philip Gribbon in Exscalate4CoV (2023)

  4. Article

    Open Access

    Cytopathic SARS-CoV-2 screening on VERO-E6 cells in a large-scale repurposing effort

    Worldwide, there are intensive efforts to identify repurposed drugs as potential therapies against SARS-CoV-2 infection and the associated COVID-19 disease. To date, the anti-inflammatory drug dexamethasone an...

    Andrea Zaliani, Laura Vangeel, Jeanette Reinshagen, Daniela Iaconis in Scientific Data (2022)

  5. Article

    Open Access

    Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants

    The new coronavirus SARS-CoV-2 is the causative agent of the COVID-19 pandemic, which so far has caused over 6 million deaths in 2 years, despite new vaccines and antiviral medications. Drug repurposing, an ap...

    Daniela Iaconis, Licia Bordi, Giulia Matusali, Carmine Talarico in Cell Death & Disease (2022)

  6. Article

    Open Access

    Paclitaxel binds and activates C5aR1: A new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactions

    Chemotherapy-induced peripheral neuropathy (CIPN) and hypersensitivity reactions (HSRs) are among the most frequent and impairing side effects of the antineoplastic agent paclitaxel. Here, we demonstrated that...

    Laura Brandolini, Michele d’Angelo, Rubina Novelli in Cell Death & Disease (2022)

  7. Article

    Open Access

    Development of a novel SNP assay to detect lactase persistence associated genetic variants

    In adulthood the activity of the lactase enzyme is inherited as autosomal dominant form associated to Single nucleotide polymorphisms (SNPs). The present research was aimed to develop a novel genetic method to...

    Pasquale De Luca, Daniela Iaconis, Elio Biffali, Coluccia Enza in Molecular Biology Reports (2021)

  8. Article

    Open Access

    The centrosomal OFD1 protein interacts with the translation machinery and regulates the synthesis of specific targets

    Protein synthesis is traditionally associated with specific cytoplasmic compartments. We now show that OFD1, a centrosomal/basal body protein, interacts with components of the Preinitiation complex of translat...

    Daniela Iaconis, Maria Monti, Mario Renda, Arianne van Koppen in Scientific Reports (2017)

  9. Article

    Open Access

    An organelle-specific protein landscape identifies novel diseases and molecular mechanisms

    Cellular organelles provide opportunities to relate biological mechanisms to disease. Here we use affinity proteomics, genetics and cell biology to interrogate cilia: poorly understood organelles, where defect...

    Karsten Boldt, Jeroen van Reeuwijk, Qianhao Lu in Nature Communications (2016)